img

Global Human Blood Plasma Fractionation Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Blood Plasma Fractionation Market Insights, Forecast to 2034

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
Market Analysis and InsightsGlobal Human Blood Plasma Fractionation Market
Global Human Blood Plasma Fractionation market is expected to reach to US$ 32700 million in 2024, with a positive growth of %, compared with US$ 30330 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Blood Plasma Fractionation industry is evaluated to reach US$ 50750 million in 2029. The CAGR will be 7.6% during 2024 to 2029.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
Report Covers
This report presents an overview of global Human Blood Plasma Fractionation market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Blood Plasma Fractionation market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Others

Segment by Application


Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Human Blood Plasma Fractionation introduction, etc. Human Blood Plasma Fractionation Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Human Blood Plasma Fractionation
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Blood Plasma Fractionation Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Blood Plasma Fractionation Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Blood Plasma Fractionation Market Perspective (2018-2029)
2.2 Global Human Blood Plasma Fractionation Growth Trends by Region
2.2.1 Human Blood Plasma Fractionation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Blood Plasma Fractionation Historic Market Size by Region (2018-2024)
2.2.3 Human Blood Plasma Fractionation Forecasted Market Size by Region (2024-2029)
2.3 Human Blood Plasma Fractionation Market Dynamics
2.3.1 Human Blood Plasma Fractionation Industry Trends
2.3.2 Human Blood Plasma Fractionation Market Drivers
2.3.3 Human Blood Plasma Fractionation Market Challenges
2.3.4 Human Blood Plasma Fractionation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Blood Plasma Fractionation by Players
3.1.1 Global Human Blood Plasma Fractionation Revenue by Players (2018-2024)
3.1.2 Global Human Blood Plasma Fractionation Revenue Market Share by Players (2018-2024)
3.2 Global Human Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Blood Plasma Fractionation, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Human Blood Plasma Fractionation Market Concentration Ratio
3.4.1 Global Human Blood Plasma Fractionation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Blood Plasma Fractionation Revenue in 2022
3.5 Global Key Players of Human Blood Plasma Fractionation Head office and Area Served
3.6 Global Key Players of Human Blood Plasma Fractionation, Product and Application
3.7 Global Key Players of Human Blood Plasma Fractionation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Blood Plasma Fractionation Breakdown Data by Type
4.1 Global Human Blood Plasma Fractionation Historic Market Size by Type (2018-2024)
4.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2024-2029)
5 Human Blood Plasma Fractionation Breakdown Data by Application
5.1 Global Human Blood Plasma Fractionation Historic Market Size by Application (2018-2024)
5.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Blood Plasma Fractionation Market Size (2018-2029)
6.2 North America Human Blood Plasma Fractionation Market Size by Type
6.2.1 North America Human Blood Plasma Fractionation Market Size by Type (2018-2024)
6.2.2 North America Human Blood Plasma Fractionation Market Size by Type (2024-2029)
6.2.3 North America Human Blood Plasma Fractionation Market Share by Type (2018-2029)
6.3 North America Human Blood Plasma Fractionation Market Size by Application
6.3.1 North America Human Blood Plasma Fractionation Market Size by Application (2018-2024)
6.3.2 North America Human Blood Plasma Fractionation Market Size by Application (2024-2029)
6.3.3 North America Human Blood Plasma Fractionation Market Share by Application (2018-2029)
6.4 North America Human Blood Plasma Fractionation Market Size by Country
6.4.1 North America Human Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Human Blood Plasma Fractionation Market Size by Country (2018-2024)
6.4.3 North America Human Blood Plasma Fractionation Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Blood Plasma Fractionation Market Size (2018-2029)
7.2 Europe Human Blood Plasma Fractionation Market Size by Type
7.2.1 Europe Human Blood Plasma Fractionation Market Size by Type (2018-2024)
7.2.2 Europe Human Blood Plasma Fractionation Market Size by Type (2024-2029)
7.2.3 Europe Human Blood Plasma Fractionation Market Share by Type (2018-2029)
7.3 Europe Human Blood Plasma Fractionation Market Size by Application
7.3.1 Europe Human Blood Plasma Fractionation Market Size by Application (2018-2024)
7.3.2 Europe Human Blood Plasma Fractionation Market Size by Application (2024-2029)
7.3.3 Europe Human Blood Plasma Fractionation Market Share by Application (2018-2029)
7.4 Europe Human Blood Plasma Fractionation Market Size by Country
7.4.1 Europe Human Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Human Blood Plasma Fractionation Market Size by Country (2018-2024)
7.4.3 Europe Human Blood Plasma Fractionation Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Blood Plasma Fractionation Market Size (2018-2029)
8.2 China Human Blood Plasma Fractionation Market Size by Type
8.2.1 China Human Blood Plasma Fractionation Market Size by Type (2018-2024)
8.2.2 China Human Blood Plasma Fractionation Market Size by Type (2024-2029)
8.2.3 China Human Blood Plasma Fractionation Market Share by Type (2018-2029)
8.3 China Human Blood Plasma Fractionation Market Size by Application
8.3.1 China Human Blood Plasma Fractionation Market Size by Application (2018-2024)
8.3.2 China Human Blood Plasma Fractionation Market Size by Application (2024-2029)
8.3.3 China Human Blood Plasma Fractionation Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Blood Plasma Fractionation Market Size (2018-2029)
9.2 Asia Human Blood Plasma Fractionation Market Size by Type
9.2.1 Asia Human Blood Plasma Fractionation Market Size by Type (2018-2024)
9.2.2 Asia Human Blood Plasma Fractionation Market Size by Type (2024-2029)
9.2.3 Asia Human Blood Plasma Fractionation Market Share by Type (2018-2029)
9.3 Asia Human Blood Plasma Fractionation Market Size by Application
9.3.1 Asia Human Blood Plasma Fractionation Market Size by Application (2018-2024)
9.3.2 Asia Human Blood Plasma Fractionation Market Size by Application (2024-2029)
9.3.3 Asia Human Blood Plasma Fractionation Market Share by Application (2018-2029)
9.4 Asia Human Blood Plasma Fractionation Market Size by Region
9.4.1 Asia Human Blood Plasma Fractionation Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Human Blood Plasma Fractionation Market Size by Region (2018-2024)
9.4.3 Asia Human Blood Plasma Fractionation Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Human Blood Plasma Fractionation Introduction
11.1.4 Takeda Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Human Blood Plasma Fractionation Introduction
11.2.4 CSL Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Human Blood Plasma Fractionation Introduction
11.3.4 Grifols Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Human Blood Plasma Fractionation Introduction
11.4.4 Octapharma Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Human Blood Plasma Fractionation Introduction
11.5.4 Kedrion Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Human Blood Plasma Fractionation Introduction
11.6.4 LFB Group Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Human Blood Plasma Fractionation Introduction
11.7.4 Biotest Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Human Blood Plasma Fractionation Introduction
11.8.4 BPL Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Human Blood Plasma Fractionation Introduction
11.9.4 RAAS Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Human Blood Plasma Fractionation Introduction
11.10.4 CBPO Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.10.5 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Human Blood Plasma Fractionation Introduction
11.11.4 Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.11.5 Hualan Bio Recent Developments
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Human Blood Plasma Fractionation Introduction
11.12.4 Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.12.5 Tiantan Bio Recent Developments
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Human Blood Plasma Fractionation Introduction
11.13.4 Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.13.5 Shuanglin Bio Recent Developments
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Human Blood Plasma Fractionation Introduction
11.14.4 Boya Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.14.5 Boya Bio Recent Developments
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Introduction
11.15.4 Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.15.5 Yuanda Shuyang Recent Developments
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Human Blood Plasma Fractionation Introduction
11.16.4 Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.16.5 Weiguang Bio Recent Developments
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Human Blood Plasma Fractionation Introduction
11.17.4 Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.17.5 Nanyue Bio Recent Developments
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Human Blood Plasma Fractionation Introduction
11.18.4 KM Biologics Revenue in Human Blood Plasma Fractionation Business (2018-2024)
11.18.5 KM Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Others
Table 6. Global Human Blood Plasma Fractionation Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Human Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Human Blood Plasma Fractionation Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Human Blood Plasma Fractionation Market Share by Region (2018-2024)
Table 10. Global Human Blood Plasma Fractionation Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Human Blood Plasma Fractionation Market Share by Region (2024-2029)
Table 12. Human Blood Plasma Fractionation Market Trends
Table 13. Human Blood Plasma Fractionation Market Drivers
Table 14. Human Blood Plasma Fractionation Market Challenges
Table 15. Human Blood Plasma Fractionation Market Restraints
Table 16. Global Human Blood Plasma Fractionation Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Human Blood Plasma Fractionation Revenue Share by Players (2018-2024)
Table 18. Global Top Human Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2022)
Table 19. Global Human Blood Plasma Fractionation Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Human Blood Plasma Fractionation Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Human Blood Plasma Fractionation, Headquarters and Area Served
Table 22. Global Key Players of Human Blood Plasma Fractionation, Product and Application
Table 23. Global Key Players of Human Blood Plasma Fractionation, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2018-2024)
Table 27. Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2024-2029)
Table 29. Global Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Human Blood Plasma Fractionation Revenue Share by Application (2018-2024)
Table 31. Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Human Blood Plasma Fractionation Revenue Share by Application (2024-2029)
Table 33. North America Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Human Blood Plasma Fractionation Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Human Blood Plasma Fractionation Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Human Blood Plasma Fractionation Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Human Blood Plasma Fractionation Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Human Blood Plasma Fractionation Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Human Blood Plasma Fractionation Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Human Blood Plasma Fractionation Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Human Blood Plasma Fractionation Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Human Blood Plasma Fractionation Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Human Blood Plasma Fractionation Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Human Blood Plasma Fractionation Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Human Blood Plasma Fractionation Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Human Blood Plasma Fractionation Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Human Blood Plasma Fractionation Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Human Blood Plasma Fractionation Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Human Blood Plasma Fractionation Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Human Blood Plasma Fractionation Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size by Country (2024-2029) & (US$ Million)
Table 65. Takeda Company Details
Table 66. Takeda Business Overview
Table 67. Takeda Human Blood Plasma Fractionation Product
Table 68. Takeda Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 69. Takeda Recent Developments
Table 70. CSL Company Details
Table 71. CSL Business Overview
Table 72. CSL Human Blood Plasma Fractionation Product
Table 73. CSL Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 74. CSL Recent Developments
Table 75. Grifols Company Details
Table 76. Grifols Business Overview
Table 77. Grifols Human Blood Plasma Fractionation Product
Table 78. Grifols Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 79. Grifols Recent Developments
Table 80. Octapharma Company Details
Table 81. Octapharma Business Overview
Table 82. Octapharma Human Blood Plasma Fractionation Product
Table 83. Octapharma Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 84. Octapharma Recent Developments
Table 85. Kedrion Company Details
Table 86. Kedrion Business Overview
Table 87. Kedrion Human Blood Plasma Fractionation Product
Table 88. Kedrion Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 89. Kedrion Recent Developments
Table 90. LFB Group Company Details
Table 91. LFB Group Business Overview
Table 92. LFB Group Human Blood Plasma Fractionation Product
Table 93. LFB Group Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 94. LFB Group Recent Developments
Table 95. Biotest Company Details
Table 96. Biotest Business Overview
Table 97. Biotest Human Blood Plasma Fractionation Product
Table 98. Biotest Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 99. Biotest Recent Developments
Table 100. BPL Company Details
Table 101. BPL Business Overview
Table 102. BPL Human Blood Plasma Fractionation Product
Table 103. BPL Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 104. BPL Recent Developments
Table 105. RAAS Company Details
Table 106. RAAS Business Overview
Table 107. RAAS Human Blood Plasma Fractionation Product
Table 108. RAAS Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 109. RAAS Recent Developments
Table 110. CBPO Company Details
Table 111. CBPO Business Overview
Table 112. CBPO Human Blood Plasma Fractionation Product
Table 113. CBPO Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 114. CBPO Recent Developments
Table 115. Hualan Bio Company Details
Table 116. Hualan Bio Business Overview
Table 117. Hualan Bio Human Blood Plasma Fractionation Product
Table 118. Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 119. Hualan Bio Recent Developments
Table 120. Tiantan Bio Company Details
Table 121. Tiantan Bio Business Overview
Table 122. Tiantan Bio Human Blood Plasma Fractionation Product
Table 123. Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 124. Tiantan Bio Recent Developments
Table 125. Shuanglin Bio Company Details
Table 126. Shuanglin Bio Business Overview
Table 127. Shuanglin Bio Human Blood Plasma Fractionation Product
Table 128. Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 129. Shuanglin Bio Recent Developments
Table 130. Boya Bio Company Details
Table 131. Boya Bio Business Overview
Table 132. Boya Bio Human Blood Plasma Fractionation Product
Table 133. Boya Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 134. Boya Bio Recent Developments
Table 135. Yuanda Shuyang Company Details
Table 136. Yuanda Shuyang Business Overview
Table 137. Yuanda Shuyang Human Blood Plasma Fractionation Product
Table 138. Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 139. Yuanda Shuyang Recent Developments
Table 140. Weiguang Bio Company Details
Table 141. Weiguang Bio Business Overview
Table 142. Weiguang Bio Human Blood Plasma Fractionation Product
Table 143. Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 144. Weiguang Bio Recent Developments
Table 145. Nanyue Bio Company Details
Table 146. Nanyue Bio Business Overview
Table 147. Nanyue Bio Human Blood Plasma Fractionation Product
Table 148. Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 149. Nanyue Bio Recent Developments
Table 150. KM Biologics Company Details
Table 151. KM Biologics Business Overview
Table 152. KM Biologics Human Blood Plasma Fractionation Product
Table 153. KM Biologics Revenue in Human Blood Plasma Fractionation Business (2018-2024) & (US$ Million)
Table 154. KM Biologics Recent Developments
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Blood Plasma Fractionation Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Human Blood Plasma Fractionation Market Share by Type: 2022 VS 2029
Figure 3. Immune Globulin Features
Figure 4. Coagulation Factor Features
Figure 5. Albumin Features
Figure 6. Others Features
Figure 7. Global Human Blood Plasma Fractionation Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Human Blood Plasma Fractionation Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Human Blood Plasma Fractionation Report Years Considered
Figure 13. Global Human Blood Plasma Fractionation Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Human Blood Plasma Fractionation Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Blood Plasma Fractionation Market Share by Region: 2022 VS 2029
Figure 16. Global Human Blood Plasma Fractionation Market Share by Players in 2022
Figure 17. Global Top Human Blood Plasma Fractionation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Human Blood Plasma Fractionation Revenue in 2022
Figure 19. North America Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Human Blood Plasma Fractionation Market Share by Type (2018-2029)
Figure 21. North America Human Blood Plasma Fractionation Market Share by Application (2018-2029)
Figure 22. North America Human Blood Plasma Fractionation Market Share by Country (2018-2029)
Figure 23. United States Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Human Blood Plasma Fractionation Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Human Blood Plasma Fractionation Market Share by Type (2018-2029)
Figure 27. Europe Human Blood Plasma Fractionation Market Share by Application (2018-2029)
Figure 28. Europe Human Blood Plasma Fractionation Market Share by Country (2018-2029)
Figure 29. Germany Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Human Blood Plasma Fractionation Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Human Blood Plasma Fractionation Market Share by Type (2018-2029)
Figure 37. China Human Blood Plasma Fractionation Market Share by Application (2018-2029)
Figure 38. Asia Human Blood Plasma Fractionation Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Human Blood Plasma Fractionation Market Share by Type (2018-2029)
Figure 40. Asia Human Blood Plasma Fractionation Market Share by Application (2018-2029)
Figure 41. Asia Human Blood Plasma Fractionation Market Share by Region (2018-2029)
Figure 42. Japan Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Human Blood Plasma Fractionation Market Share by Country (2018-2029)
Figure 52. Brazil Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Human Blood Plasma Fractionation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Takeda Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 59. CSL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 60. Grifols Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 61. Octapharma Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 62. Kedrion Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 63. LFB Group Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 64. Biotest Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 65. BPL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 66. RAAS Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 67. CBPO Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 68. Hualan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 69. Tiantan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 70. Shuanglin Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 71. Boya Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 72. Yuanda Shuyang Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 73. Weiguang Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 74. Nanyue Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 75. KM Biologics Revenue Growth Rate in Human Blood Plasma Fractionation Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries